Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Carcinoma, Oat Cell

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Carcinoma, Oat Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aisner, J; Carney, D; Fuks, JZ; Ihde, DC; Levitt, M; Van Echo, DA; Wiernik, PH1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Carcinoma, Oat Cell

ArticleYear
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
    American journal of clinical oncology, 1983, Volume: 6, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carcinoma, Small Cell; Cyclohexenes; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged

1983